Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2022-10-03 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
General updates
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. It is issued by the Registrar and Share Transfer Agent confirming compliance related to dematerialisation of securities for the quarter ended 30th September 2022. The content is a compliance certificate and does not contain financial statements, management discussion, or detailed financial data. It is a regulatory compliance filing related to securities dematerialisation and share transfer agent confirmation. The document length is 4077 characters, which is relatively short and focused on certification. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate and not a full financial report or announcement of a report.
2022-10-03 English
Pursuant to Regulation 74 (5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we are enclosing herewith Certificate dated 1st July, 2022 ....
Regulatory Filings
2022-10-03 English
Pursuant to the above Regulations, we wish to inform that the Trading Window for dealing in securities of Wanbury Limited (the "Company") shall remain closed for the Designated Persons ....
Regulatory Filings
2022-09-30 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is very short (602 characters) and contains a digital signature block with no substantive financial data, report content, or detailed information. It appears to be an officer certification or attestation rather than a full report or announcement. There is no mention of financial results, meeting materials, or regulatory filings beyond the signature. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2022-09-30 English
Annual General Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the submission of voting results from the 34th Annual General Meeting (AGM) held on 28th September 2022. It references Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which pertains to disclosure of voting results. The document includes detailed voting results and a scrutinizer report, which are typical components of a voting results announcement. There is no indication that this document is the AGM presentation materials themselves, nor is it a full annual report or financial statement. The document is not a proxy solicitation or remuneration report. It is clearly an official announcement of the voting results from the AGM, which fits the category of "Declaration of Voting Results & Voting Rights Announcements" (DVA). The document length and content support this classification with high confidence.
2022-09-28 English
Pursuant to Regulation 44 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are enclosing herewith the Voting Results of the 34th Annual General Meeting ....
Regulatory Filings
2022-09-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.